Prognostic impact of baseline blood biomarkers in SCLC first-line treatment.

Published 2025-01-01 · Journal article · DOI 10.1177/17588359261450062

Authors being retrieved — see the publisher record. https://doi.org/10.1177/17588359261450062

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2025

Related articles

• Assessment of systematic inflammatory and nutritional indexes in extensive-stage small-cell lung cancer treated with first-line chemotherapy and atezolizumab · Cancer Immunology, Immunotherapy · 2021 · Cites or is cited by this article